Antiphospholipid antibodies in response to infection

被引：65
作者：
Avčin T. [1 ]
Toplak N. [1 ]
机构：
[1] Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital, University Medical Center Ljubljana, SI-1525 Ljubljana
来源：
Current Rheumatology Reports | 2007年 / 9卷 / 3期
关键词：
Anticardiolipin Antibody; Acute Rheumatic Fever; Fusobacterium Necrophorum; Lemierre Syndrome; Pholipid Syndrome;
D O I：
10.1007/s11926-007-0034-x
中图分类号：
学科分类号：
摘要：
An association between infections and antiphospholipid antibodies (aPL) has been reported in several epidemiologic and experimental studies. Infection-induced aPL have been traditionally regarded as transient and were generally not associated with clinical features of antiphospholipid syndrome. The distinction between autoimmune and postinfectious aPL on the basis of requirement of binding cofactor is not absolute, and in recent years, several reports demonstrated that some patients can produce pathogenic antibodies in response to infection. Infections most frequently associated with antiphospholipid syndrome include parvovirus B19, cytomegalovirus, varicella-zoster virus, HIV, streptococcal and staphylococcal infections, gram-negative bacteria, and Mycoplasma pneumoniae. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码：212 / 218
页数：6
相关论文
共 54 条
[1]  
Levine J.S., Branch D.W., Rauch J., The antiphospholipid syndrome, N Engl J Med, 346, pp. 752-763, (2002)
[2]  
Shoenfeld Y., Blank M., Cervera R., Et al., Infectious origin of the antiphospholipid syndrome, Ann Rheum Dis, 65, pp. 2-6, (2006)
[3]  
Luong T.H., Rand J.H., Wu X.X., Et al., Seasonal distribution of antiphospholipid antibodies, Stroke, 32, pp. 1707-1711, (2001)
[4]  
Avcin T., Ambrozic A., Kuhar M., Et al., Anticardiolipin and anti-beta2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits, Rheumatology, 40, pp. 565-573, (2001)
[5]  
McNally T., Purdy G., Mackie I.J., Et al., The use of an anti-beta2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis, Br J Haematol, 91, pp. 471-473, (1995)
[6]  
Asherson R.A., Cervera R., Piette J.C., Et al., Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients, Medicine, 80, pp. 355-377, (2001)
[7]  
Kratz C., Mauz-Korholz C., Kruck H., Et al., Detection of antiphospholipid antibodies in children and adolescents, Pediatr Hematol Oncol, 15, pp. 325-332, (1998)
[8]  
Frauenknecht K., Lackner K., von Landenberg P., Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection, Immunobiology, 210, pp. 799-805, (2005)
[9]  
Vaarala O., Palosuo T., Kleemola M., Aho K., Anticardiolipin response in acute infections, Clin Immunol Immunopathol, 41, pp. 8-15, (1986)
[10]  
Von Landenberg P., Lehmann H.W., Knoll A., Et al., Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection, Arthritis Rheum, 48, pp. 1939-1947, (2003)
123456